Immunosuppressive Drugs in Early Systemic Sclerosis and Prevention of Damage Accrual

OBJECTIVE: Organ damage in patients with systemic sclerosis (SSc) in individual organs such as the lungs may be prevented by receiving immunosuppressive drugs (ISs). A new measure of global organ damage, the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI), has allowed us to investigate whether receiving ISs may reduce global organ damage accrual in patients with early SSc. METHODS: This was a retrospective study of patients with …